Page last updated: 2024-10-27

fenofibrate and Nephrolithiasis

fenofibrate has been researched along with Nephrolithiasis in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Nephrolithiasis: Formation of stones in the KIDNEY.

Research Excerpts

ExcerptRelevanceReference
"Recently, nephrolithiasis has been reported to be involved with renal manifestation of metabolic syndrome."2.73Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH. ( Inokuchi, T; Ka, T; Kobayashi, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, S1
Inokuchi, T1
Kobayashi, T1
Ka, T1
Tsutsumi, Z1
Moriwaki, Y1
Yamamoto, T1

Trials

1 trial available for fenofibrate and Nephrolithiasis

ArticleYear
Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2007, Volume: 39, Issue:7

    Topics: Bezafibrate; Biomarkers; Body Mass Index; Fenofibrate; Gout; Humans; Hydrogen-Ion Concentration; Hyp

2007